Company / Accounts Receivable
Revvity Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$744.7M
FY2025
5-year range
$612.8M / $744.7M
FY2021-FY2025
Trend
+17.8%
vs FY2024
Sector context
#32 of 138
Health Care
What the data says
Revvity's accounts receivable of $745M is higher than 77% of companies in the Health Care sector (FY2025). Accounts Receivable has fluctuated over the past 10 years, ranging from $426M in FY2016 to $1.2B in FY2020.
Based on SEC 10-K filings.
$745M in FY2025 with a 5-year CAGR of -8.4%. Top quartile in the Health Care sector.
Improved from $633M to $745M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- -8.4%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 138This company $744.7M Sector average $1.3B
▼
-43.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.4%, indicating a declining trend.
- In FY2025, accounts receivable increased 17.8% year-over-year.
- Ranks #32 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2020.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $744.7M | +17.8% |
| FY2024 | $632.4M | -0.1% |
| FY2023 | $632.8M | +3.3% |
| FY2022 | $612.8M | -13.4% |
| FY2021 | $707.9M | -38.7% |
| FY2020 | $1.2B | +59.3% |
| FY2019 | $725.2M | +14.6% |
| FY2018 | $632.7M | +14.6% |
| FY2017 | $552.3M | +29.8% |
| FY2016 | $425.6M | +2.5% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026